| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 27.048 | 45.127 | 55.109 | 67.957 | 65.102 | 64.510 | 75.384 | 98.382 | 115.493 |
| Total Income - EUR | - | 27.048 | 45.129 | 55.110 | 67.958 | 68.807 | 64.511 | 75.404 | 98.383 | 115.495 |
| Total Expenses - EUR | - | 9.511 | 16.355 | 26.713 | 23.283 | 29.275 | 25.535 | 27.188 | 27.550 | 30.769 |
| Gross Profit/Loss - EUR | - | 17.537 | 28.773 | 28.397 | 44.675 | 39.532 | 38.976 | 48.215 | 70.833 | 84.726 |
| Net Profit/Loss - EUR | - | 17.267 | 28.322 | 27.846 | 43.995 | 38.925 | 38.344 | 47.476 | 70.006 | 81.330 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Liptakmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 2.931 | 2.110 | 1.843 | 1.176 | 423 | 339 | 254 | 252 |
| Current Assets | - | 18.223 | 26.427 | 26.928 | 43.389 | 41.144 | 39.323 | 49.270 | 79.425 | 83.747 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 4.448 | 3.944 | 4.565 | 5.469 | 5.430 | 5.593 | 35.553 | 15.902 | 58.976 |
| Cash | - | 13.775 | 22.484 | 22.363 | 37.919 | 35.715 | 33.731 | 13.717 | 63.523 | 24.771 |
| Shareholders Funds | - | 17.311 | 28.375 | 27.898 | 44.046 | 38.975 | 38.392 | 47.525 | 77.623 | 81.378 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 912 | 983 | 1.140 | 1.186 | 3.345 | 1.354 | 2.084 | 2.056 | 2.621 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Liptakmed Srl